Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - HARROW HEALTH, INC. | c92614e10vq.htm |
| EX-31.1 - EX-31.1 - HARROW HEALTH, INC. | c92614exv31w1.htm |
| EX-31.2 - EX-31.2 - HARROW HEALTH, INC. | c92614exv31w2.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Transdel Pharmaceuticals, Inc. (the “Company”) on Form
10-Q for the period ended September 30, 2009 as filed with the Securities and Exchange Commission
on the date hereof (the “Report”) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, Juliet Singh, Ph.D., the Chief Executive Officer of
Transdel Pharmaceuticals, Inc., and John T. Lomoro, the Chief Financial Officer of Transdel
Pharmaceuticals, Inc., each certifies that:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
| (2) | the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations
of the Company. |
Dated: November 16, 2009
| /s/ Juliet Singh | ||||
| Juliet Singh, Ph.D. | ||||
| Chief Executive Officer (Principal Executive Officer) |
||||
| /s/ John T. Lomoro | ||||
| John T. Lomoro | ||||
| Chief Financial Officer (Principal Financial Officer) |
||||